NTCP opens the door for hepatitis B virus infection

Antiviral Research

Volumn 121, Issue , 2015, Pages 24-30

  Yan, Huan ^a,b   Liu, Yang ^a,c   Sui, Jianhua ^a   Li, Wenhui ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^b PEKING UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

Cell culture; Drug development; Hepatitis B virus; Hepatitis D virus; Receptor; Sodium taurocholate cotransporting polypeptide (NTCP)

Indexed keywords

SODIUM BILE ACID COTRANSPORTER; VIRUS RECEPTOR; COTRANSPORTER; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER;

ARTICLE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; HEPG2 CELL LINE; HUMAN; LIVER CELL; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ENTRY;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATOCYTES; HUMANS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RECEPTORS, VIRUS; SYMPORTERS; VIRUS INTERNALIZATION;

EID: 84934273603     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.06.002     Document Type: Review

References (72)

1. M.S. Anwer, and B. Stieger Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters Pflugers Arch. 466 2014 77 89
2. A. Barrera, B. Guerra, L. Notvall, and R.E. Lanford Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition J. Virol. 79 2005 9786 9798
3. M. Blanchet, and C. Sureau Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues J. Virol. 81 2007 5841 5849
4. M. Blanchet, C. Sureau, and P. Labonte Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle Antiviral Res. 106 2014 111 115
5. T.M. Block, R. Gish, H. Guo, A. Mehta, A. Cuconati, W. Thomas London, and J.T. Guo Chronic hepatitis B: what should be the goal for new therapies? Antiviral Res. 98 2013 27 34
6. F. Bouezzedine, O. Fardel, and P. Gripon Interleukin 6 inhibits HBV entry through NTCP down regulation Virology 481 2015 34 42
7. S.W. Chi, D.H. Kim, S.H. Lee, I. Chang, and K.H. Han Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus Protein Sci. 16 2007 2108 2117
8. Z. Dong, S. Ekins, and J.E. Polli Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition Eur. J. Pharm. Sci. 66C 2014 1 9
9. Z. Dong, S. Ekins, and J.E. Polli A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide Int. J. Pharm. 478 2014 88 95
10. B. Doring, T. Lutteke, J. Geyer, and E. Petzinger The SLC10 carrier family: transport functions and molecular structure Curr. Top. Membr. 70 2012 105 168
11. J.F. Drexler, A. Geipel, A. Konig, V.M. Corman, D. van Riel, L.M. Leijten, C.M. Bremer, A. Rasche, V.M. Cottontail, and G.D. Maganga Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes Proc. Natl. Acad. Sci. U.S.A. 110 2013 16151 16156
12. M. Engelke, K. Mills, S. Seitz, P. Simon, P. Gripon, M. Schnolzer, and S. Urban Characterization of a hepatitis B and hepatitis delta virus receptor binding site Hepatology 43 2006 750 760
13. D. Fernholz, P.R. Galle, M. Stemler, M. Brunetto, F. Bonino, and H. Will Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier Virology 194 1993 137 148
14. D. Ganem, and H.E. Varmus The molecular biology of the hepatitis B viruses Annu. Rev. Biochem. 56 1987 651 693
15. D. Glebe, M. Aliakbari, P. Krass, E.V. Knoop, K.P. Valerius, and W.H. Gerlich Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus J. Virol. 77 2003 9511 9521
16. D. Glebe, and S. Urban Viral and cellular determinants involved in hepadnaviral entry World J. Gastroenterol. 13 2007 22 38
17. D. Glebe, S. Urban, E.V. Knoop, N. Cag, P. Krass, S. Grun, A. Bulavaite, K. Sasnauskas, and W.H. Gerlich Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and Tupaia hepatocytes Gastroenterology 129 2005 234 245
18. P. Gripon, I. Cannie, and S. Urban Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein J. Virol. 79 2005 1613 1622
19. P. Gripon, C. Diot, N. Theze, I. Fourel, O. Loreal, C. Brechot, and C. Guguen-Guillouzo Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide J. Virol. 62 1988 4136 4143
20. P. Gripon, J. Le Seyec, S. Rumin, and C. Guguen-Guillouzo Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity Virology 213 1995 292 299
21. P. Gripon, S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo Infection of a human hepatoma cell line by hepatitis B virus Proc. Natl. Acad. Sci. U.S.A. 99 2002 15655 15660
22. B. Hagenbuch, and P.J. Meier Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter J. Clin. Invest. 93 1994 1326 1331
23. W. He, B. Ren, F. Mao, Z. Jing, Y. Li, Y. Liu, B. Peng, H. Yan, Y. Qi, and Y. Sun Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide PLoS Pathog. 11 2015 e1004840
24. K.H. Heermann, U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W.H. Gerlich Large surface proteins of hepatitis B virus containing the pre-s sequence J. Virol. 52 1984 396 402
25. H.J. Hong, C.J. Ryu, H. Hur, S. Kim, H.K. Oh, M.S. Oh, and S.Y. Park In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees Virology 318 2004 134 141
26. N.J. Hu, S. Iwata, A.D. Cameron, and D. Drew Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT Nature 478 2011 408 411
27. H.C. Huang, M.H. Tao, T.M. Hung, J.C. Chen, Z.J. Lin, and C. Huang (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes Antiviral Res. 111 2014 100 111
28. M. Iwamoto, K. Watashi, S. Tsukuda, H.H. Aly, M. Fukasawa, A. Fujimoto, R. Suzuki, H. Aizaki, T. Ito, and O. Koiwai Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP Biochem. Biophys. Res. Commun. 443 2014 808 813
29. C. Ko, W.J. Park, S. Park, S. Kim, M.P. Windisch, and W.S. Ryu The FDA approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide Antiv. Ther. 2015 10.3851/IMP2965
30. A. König, B. Doring, C. Mohr, A. Geipel, J. Geyer, and D. Glebe Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes J. Hepatol. 61 2014 867 875
31. Y. Le Duff, M. Blanchet, and C. Sureau The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent J. Virol. 83 2009 12443 12451
32. J. Le Seyec, P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain J. Virol. 73 1999 2052 2057
33. M. Le Vee, E. Jouan, B. Stieger, V. Lecureur, and O. Fardel Regulation of drug transporter expression by oncostatin M in human hepatocytes Biochem. Pharmacol. 82 2011 304 311
34. M. Le Vee, V. Lecureur, B. Stieger, and O. Fardel Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6 Drug Metab. Dispos. 37 2009 685 693
35. C.M. Leistner, S. Gruen-Bernhard, and D. Glebe Role of glycosaminoglycans for binding and infection of hepatitis B virus Cell. Microbiol. 10 2008 122 133
36. S. Locarnini, A. Hatzakis, D.S. Chen, and A. Lok Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs J. Hepatol. 62 2015 S76 S86
37. J. Lucifora, K. Esser, and U. Protzer Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes Antiviral Res. 97 2013 195 197
38. C.Y. Maeng, C.J. Ryu, P. Gripon, C. Guguen-Guillouzo, and H.J. Hong Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1 Virology 270 2000 9 16
39. A. Meier, S. Mehrle, T.S. Weiss, W. Mier, and S. Urban Myristoylated PreS1-domain of the hepatitis B virus l-protein mediates specific binding to differentiated hepatocytes Hepatology 58 2013 31 42
40. A.R. Neurath, B. Seto, and N. Strick Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective Vaccine 7 1989 234 236
41. Y. Ni, F.A. Lempp, S. Mehrle, S. Nkongolo, C. Kaufman, M. Falth, J. Stindt, C. Koniger, M. Nassal, and R. Kubitz Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes Gastroenterology 146 2014 1070 1083
42. S. Nkongolo, Y. Ni, F.A. Lempp, C. Kaufman, T. Lindner, K. Esser-Nobis, V. Lohmann, W. Mier, S. Mehrle, and S. Urban Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor J. Hepatol. 60 2014 723 731
43. N. Oehler, T. Volz, O.D. Bhadra, J. Kah, L. Allweiss, K. Giersch, J. Bierwolf, K. Riecken, J.M. Pollok, and A.W. Lohse Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism Hepatology 60 2014 1483 1493
44. L. Peng, Q. Zhao, Q. Li, M. Li, C. Li, T. Xu, X. Jing, X. Zhu, Y. Wang, and F. Li The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B Hepatology 61 2014 1251 1260
45. J. Petersen, M. Dandri, W. Mier, M. Lutgehetmann, T. Volz, F. von Weizsacker, U. Haberkorn, L. Fischer, J.M. Pollok, and B. Erbes Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein Nat. Biotechnol. 26 2008 335 341
46. J.C. Pizarro, B. Vulliez-le Normand, M.M. Riottot, A. Budkowska, and G.A. Bentley Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus FEBS Lett. 509 2001 463 468
47. A. Schieck, A. Schulze, C. Gahler, T. Muller, U. Haberkorn, A. Alexandrov, S. Urban, and W. Mier Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts Hepatology 58 2013 43 53
48. A. Schulze, P. Gripon, and S. Urban Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans Hepatology 46 2007 1759 1768
49. A. Schulze, A. Schieck, Y. Ni, W. Mier, and S. Urban Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction J. Virol. 84 2010 1989 2000
50. C. Seeger, and W.S. Mason Molecular biology of hepatitis B virus infection Virology 479-480C 2015 672 686
51. M.A. Sells, M.L. Chen, and G. Acs Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 1005 1009
52. A. Shlomai, R.E. Schwartz, V. Ramanan, A. Bhatta, Y.P. de Jong, S.N. Bhatia, and C.M. Rice Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems Proc. Natl. Acad. Sci. U.S.A. 111 2014 12193 12198
53. D. Slijepcevic, C. Kaufman, C.G. Wichers, E.H. Gilglioni, F.A. Lempp, S. Duijst, D.R. de Waart, R.P. Oude Elferink, W. Mier, and B. Stieger Impaired uptake of conjugated bile acids and hepatitis B virus preS1-binding in Na -taurocholate cotransporting polypeptide knockout mice Hepatology 62 1 2015 207 219
54. B. Stieger The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation Handb. Exp. Pharmacol. 2011 205 259
55. C. Sureau The role of the HBV envelope proteins in the HDV replication cycle Curr. Top. Microbiol. Immunol. 307 2006 113 131
56. C. Sureau, and J. Salisse A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant Hepatology 57 2013 985 994
57. C. Sureau, J.L. Romet-Lemonne, J.I. Mullins, and M. Essex Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA Cell 47 1986 37 47
58. C. Sureau, B. Guerra, and R.E. Lanford Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion J. Virol. 67 1993 366 372
59. J.M. Taylor Hepatitis delta virus Virology 344 2006 71 76
60. S. Tsukuda, K. Watashi, M. Iwamoto, R. Suzuki, H. Aizaki, M. Okada, M. Sugiyama, S. Kojima, Y. Tanaka, and M. Mizokami Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of NTCP expression J. Biol. Chem. 290 2014 5673 5684
61. S. Urban, R. Bartenschlager, R. Kubitz, and F. Zoulim Strategies to inhibit entry of HBV and HDV into hepatocytes Gastroenterology 147 2014 48 64
62. F.M. Vaz, C.C. Paulusma, H. Huidekoper, M. de Ru, C. Lim, J. Koster, K. Ho-Mok, A.H. Bootsma, A.K. Groen, and F.G. Schaap Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype Hepatology 61 2015 260 267
63. I. Veloso Alves Pereira, B. Buchmann, L. Sandmann, K. Sprinzl, V. Schlaphoff, K. Dohner, F. Vondran, C. Sarrazin, M.P. Manns, and C. Pinto Marques Souza de Oliveira Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP) PLoS One 10 2015 e0117152
64. E. Walter, R. Keist, B. Niederost, I. Pult, and H.E. Blum Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo Hepatology 24 1996 1 5
65. K. Watashi, A. Sluder, T. Daito, S. Matsunaga, A. Ryo, S. Nagamori, M. Iwamoto, S. Nakajima, S. Tsukuda, and K. Borroto-Esoda Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) Hepatology 59 2014 1726 1737
66. H. Yan, B. Peng, W. He, G. Zhong, Y. Qi, B. Ren, Z. Gao, Z. Jing, M. Song, and G. Xu Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide J. Virol. 87 2013 7977 7991
67. H. Yan, B. Peng, Y. Liu, G. Xu, W. He, B. Ren, Z. Jing, J. Sui, and W. Li Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide J. Virol. 88 2014 3273 3284
68. H. Yan, G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, Y. Huang, Y. Qi, B. Peng, and H. Wang Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus eLife 1 2012 e00049
69. M.B. Zeisel, J. Lucifora, W.S. Mason, C. Sureau, J. Beck, M. Levrero, M. Kann, P.A. Knolle, M. Benkirane, and D. Durantel Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure Gut 2015 10.1136/gutjnl-2014-308943
70. P. Zhang, M.Y. Yu, R. Venable, H.J. Alter, and J.W. Shih Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees Proc. Natl. Acad. Sci. U.S.A. 103 2006 9214 9219
71. G. Zhong, H. Yan, H. Wang, W. He, Z. Jing, Y. Qi, L. Fu, Z. Gao, Y. Huang, and G. Xu Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes J. Virol. 87 2013 7176 7184
72. X. Zhou, E.J. Levin, Y. Pan, J.G. McCoy, R. Sharma, B. Kloss, R. Bruni, M. Quick, and M. Zhou Structural basis of the alternating-access mechanism in a bile acid transporter Nature 505 2014 569 573